PGP and ovarian carcinoma: Curcumin inhibited the expression of P-gp and CYP3A2 to enhance the bioavailability of paclitaxel and sensitized human ovarian cancer cells expressed P-gp and CYP3A2 to paclitaxel treatment [78–80].